Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator
Medtronic PLC MDT
News
-
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
Americans favor quality over quantity in pursuit of longevity
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
New Documentary Released by Medtronic: "A Voice for Health"
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
Medtronic Once Again Named One of the World's Most Ethical Companies
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years